FEG
GWPH

Financial Enhancement Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Financial Enhancement Group’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$22K – 320
2021
Q1 		$22K Hold
100
– – ﹤0.01% 149
2020
Q4 		$12K Hold
100
– – ﹤0.01% 200
2020
Q3 		$10K Hold
100
– – ﹤0.01% 173
2020
Q2 		$12K Hold
100
– – ﹤0.01% 175
2020
Q1 		$9K Hold
100
– – ﹤0.01% 203
2019
Q4 		$10K Buy
+100
New +$11.2K ﹤0.01% 197

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Financial Enhancement Group's GWPH Position: Q2 2021 in Review

Financial Enhancement Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 100 shares — an estimated $22K sold.

Financial Enhancement Group first reported a position in GWPH in Q4 2019 and held it in 6 quarters. The position peaked at $22K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Financial Enhancement Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Financial Enhancement Group sold 100 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $22K.
  • Financial Enhancement Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 6 quarters.
  • Financial Enhancement Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $22K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Financial Enhancement Group's 13F filing for Q2 2021, filed 10 Aug 2021.